AI English summary of an SEC filing — figures as filed
Kimberly-Clark KMBThe company said its Q2 2024 net sales were $5.0 billion, down 2% from a year earlier, and organic sales rose 4%. It said the figures included a negative impact of about 5% from foreign currency translation and about 1% from the divestiture of its Tissue and K-C Professional business in Brazil.
Key points
AI summaryThe company said its Q2 2024 net sales were $5.0 billion, down 2% from a year earlier, and organic sales rose 4%. It said the figures included a negative impact of about 5% from foreign currency translation and about 1% from the divestiture of its Tissue and K-C Professional business in Brazil.
Kimberly-Clark said its diluted earnings per share for Q2 were $1.61 and adjusted earnings per share were $1.96, up 19% from the prior year, and that the figures included a $0.12 headwind from currency translation. The company also said its adjusted gross margin was 36.9%, up 290 basis points from the prior year.
The company said its operating profit for Q2 was $655 million, including $190 million of costs related to its 2024 Transformation Initiative. It said adjusted operating profit rose 16%, and that currency translation had an unfavorable impact of 7 percentage points.
The company said its operating cash flow for the first half of 2024 (6 months) was $1.5 billion, compared with $1.4 billion a year earlier. It said it returned $965 million to shareholders through dividends and share repurchases, and that total debt was $8.0 billion as of June 30, 2024, consistent with levels as of December 31, 2023.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Kimberly-Clark Q2 net sales $5.0 billion, organic sales up 4%
The company said its Q2 2024 net sales were $5.0 billion, down 2% from a year earlier, and organic sales rose 4%. It said the figures included a negative impact of about 5% from foreign currency translation and about 1% from the divestiture of its Tissue and K-C Professional business in Brazil.
Source · Based on the filing body and exhibits
Q2 adjusted EPS $1.96, adjusted gross margin 36.9%
Kimberly-Clark said its diluted earnings per share for Q2 were $1.61 and adjusted earnings per share were $1.96, up 19% from the prior year, and that the figures included a $0.12 headwind from currency translation. The company also said its adjusted gross margin was 36.9%, up 290 basis points from the prior year.
Source · Based on the filing body and exhibits
Q2 operating profit $655 million, 2024 Transformation Initiative costs $190 million
The company said its operating profit for Q2 was $655 million, including $190 million of costs related to its 2024 Transformation Initiative. It said adjusted operating profit rose 16%, and that currency translation had an unfavorable impact of 7 percentage points.
Source · Based on the filing body and exhibits
First-half operating cash flow $1.5 billion, shareholder returns $965 million
The company said its operating cash flow for the first half of 2024 (6 months) was $1.5 billion, compared with $1.4 billion a year earlier. It said it returned $965 million to shareholders through dividends and share repurchases, and that total debt was $8.0 billion as of June 30, 2024, consistent with levels as of December 31, 2023.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…